Venlafaxine in Obsessive-compulsive Disorder

Archives of General Psychiatry

Volumn 53, Issue 7, 1996, Pages 653-654

  Yaryura Tobias, Jose A ^a   Neziroglu, Fugen A ^a  

^a BioBehavioral Institute Great Neck   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE; SERTRALINE; VENLAFAXINE;

DEPRESSION; DRUG SAFETY; LETTER; OBSESSION; SEROTONINERGIC SYSTEM;

ADRENERGIC UPTAKE INHIBITORS; CYCLOHEXANOLS; DOUBLE-BLIND METHOD; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 0029987210     PISSN: 0003990X     EISSN: 15383636     Source Type: Journal    
DOI: 10.1001/archpsyc.1996.01830070103016     Document Type: Letter

References (5)

1. Greist JH, Jefferson JW, Kobak KA, Katzelnick DJ, Serlin RC. Efficacy and tolerability of serotonin transport inhibitors in obsessive-compulsive disorder: a meta-analysis. Arch Gen Psychiatry. 1995;52:53-60.
2. Zajecka JM, Fawcett J, Guy C. Coexisting major depression and obsessive-compulsive disorder treated with venlafaxine. J Clin Psychopharmacol. 1990;10:152-153.
3. Yaryura-Tobias JA, Bebirian RJ, Neziroglu FA, Bhagavan HN. Obsessive-compulsive disorders as a serotonergic defect. Res Commun Psychol Psychiatry Behav. 1977;2:279-286.
4. Fabre LF, Punam III HP. An ascending single-dose tolerance study of WY$45,030, a bicyclic antidepressant, in healthy men. Curr Ther Res. 1987;42:901-909.
5. Schweizer E, Weise C, Clary C, Fox I, Rickels K. Placebo-controlled trial of venlafaxine for the treatment of major depression. J Clin Psychopharmacol. 1991;11:233-236.